North America Long Read Sequencing Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Long Read Sequencing Market Analysis

  • Medical Devices
  • Upcoming Report
  • Nov 2022
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Frequently Asked Questions

The North America Long Read Sequencing Market size will be worth USD 3,305.5 million by 2030 during the forecast period.
The North America Long Read Sequencing Market growth rate is 21.9% during the forecast period.
The surge in incidences of genetic disorders and Rising utilization of sequence analysis methodologies are the growth drivers of the North America Long Read Sequencing Market.
The technology, product, workflow, application and end-user are the factors on which the North America Long Read Sequencing Market research is based.
The major companies in the North America Long Read Sequencing Market are Illumina, Inc. (U.S), MicrobesNG (U.S), Roche Sequencing (U.S), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (U.S), Oxford Nanopore Technologies plc (U.K), Quantapore, Inc.(U.S), FG Technologies(Switzerland), BaseClearB.V (Netherlands) INSTITUTE OF INTEGRATIVE CELL BIOLOGY AND PHYSIOLOGY ( France), The Garvan Institute (Australia), Génomique (France), Takara Holdings Inc. (Japan), Genexa AG (Switzerland).